Updated Jul 16, 2026
Quaggin Susan E has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Susan E. Quaggin is a prominent figure in the pharmaceutical industry, currently serving as the Chief Scientific Officer at AbbVie Inc. She has a strong background in immunology and has contributed significantly to the development of therapies in this field.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | ABBV | AbbVie Inc. | A — Grant or award | 1.1K | $0.00 |
Susan E. Quaggin is a prominent figure in the pharmaceutical industry, currently serving as the Chief Scientific Officer at AbbVie Inc. She has a strong background in immunology and has contributed significantly to the development of therapies in this field.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Quaggin Susan E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.